Gil Blum, an analyst from Needham, reiterated the Buy rating on Sarepta Therapeutics (SRPT – Research Report). The associated price target was ...
Today’s podcast features Derek Hansen. Derek is a renowned International Sport Performance Consultant with over 35 years of experience working with athletes across all levels and disciplines in speed, ...